A recent nationwide butter recall has been escalated by the U.S. Food and Drug Administration (FDA) to a higher risk level.
The FDA raised the risk classification for the recall of one of Bunge North America Inc.’s butter products to Class II — the second-highest warning level — on Wednesday, July 30.
A Class II recall indicates “a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote," according to the FDA’s website.
Bunge, which is based in Chesterfield, Mo., initially announced a voluntary recall of 64,800 lbs. (or 1,800 cases) of its European Style Butter Blend 1 lb. product on July 14 due to undeclared milk, which was not listed on the product label.
Read Full Article Here